Cargando…

Role of Th17 Cytokines in Airway Remodeling in Asthma and Therapy Perspectives

Airway remodeling is a frequent pathological feature of severe asthma leading to permanent airway obstruction in up to 50% of cases and to respiratory disability. Although structural changes related to airway remodeling are well-characterized, immunological processes triggering and maintaining this...

Descripción completa

Detalles Bibliográficos
Autores principales: Margelidon-Cozzolino, Victor, Tsicopoulos, Anne, Chenivesse, Cécile, de Nadai, Patricia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8974749/
https://www.ncbi.nlm.nih.gov/pubmed/35386663
http://dx.doi.org/10.3389/falgy.2022.806391
_version_ 1784680265747005440
author Margelidon-Cozzolino, Victor
Tsicopoulos, Anne
Chenivesse, Cécile
de Nadai, Patricia
author_facet Margelidon-Cozzolino, Victor
Tsicopoulos, Anne
Chenivesse, Cécile
de Nadai, Patricia
author_sort Margelidon-Cozzolino, Victor
collection PubMed
description Airway remodeling is a frequent pathological feature of severe asthma leading to permanent airway obstruction in up to 50% of cases and to respiratory disability. Although structural changes related to airway remodeling are well-characterized, immunological processes triggering and maintaining this phenomenon are still poorly understood. As a consequence, no biotherapy targeting cytokines are currently efficient to treat airway remodeling and only bronchial thermoplasty may have an effect on bronchial nerves and smooth muscles with uncertain clinical relevance. Th17 cytokines, including interleukin (IL)-17 and IL-22, play a role in neutrophilic inflammation in severe asthma and may be involved in airway remodeling. Indeed, IL-17 is increased in sputum from severe asthmatic patients, induces the expression of “profibrotic” cytokines by epithelial, endothelial cells and fibroblasts, and provokes human airway smooth muscle cell migration in in vitro studies. IL-22 is also increased in asthmatic samples, promotes myofibroblast differentiation, epithelial-mesenchymal transition and proliferation and migration of smooth muscle cells in vitro. Accordingly, we also found high levels of IL-17 and IL-22 in a mouse model of dog-allergen induced asthma characterized by a strong airway remodeling. Clinical trials found no effect of therapy targeting IL-17 in an unselected population of asthmatic patients but showed a potential benefit in a sub-population of patients exhibiting a high level of airway reversibility, suggesting a potential role on airway remodeling. Anti-IL-22 therapies have not been evaluated in asthma yet but were demonstrated efficient in severe atopic dermatitis including an effect on skin remodeling. In this review, we will address the role of Th17 cytokines in airway remodeling through data from in vitro, in vivo and translational studies, and examine the potential place of Th17-targeting therapies in the treatment of asthma with airway remodeling.
format Online
Article
Text
id pubmed-8974749
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-89747492022-04-05 Role of Th17 Cytokines in Airway Remodeling in Asthma and Therapy Perspectives Margelidon-Cozzolino, Victor Tsicopoulos, Anne Chenivesse, Cécile de Nadai, Patricia Front Allergy Allergy Airway remodeling is a frequent pathological feature of severe asthma leading to permanent airway obstruction in up to 50% of cases and to respiratory disability. Although structural changes related to airway remodeling are well-characterized, immunological processes triggering and maintaining this phenomenon are still poorly understood. As a consequence, no biotherapy targeting cytokines are currently efficient to treat airway remodeling and only bronchial thermoplasty may have an effect on bronchial nerves and smooth muscles with uncertain clinical relevance. Th17 cytokines, including interleukin (IL)-17 and IL-22, play a role in neutrophilic inflammation in severe asthma and may be involved in airway remodeling. Indeed, IL-17 is increased in sputum from severe asthmatic patients, induces the expression of “profibrotic” cytokines by epithelial, endothelial cells and fibroblasts, and provokes human airway smooth muscle cell migration in in vitro studies. IL-22 is also increased in asthmatic samples, promotes myofibroblast differentiation, epithelial-mesenchymal transition and proliferation and migration of smooth muscle cells in vitro. Accordingly, we also found high levels of IL-17 and IL-22 in a mouse model of dog-allergen induced asthma characterized by a strong airway remodeling. Clinical trials found no effect of therapy targeting IL-17 in an unselected population of asthmatic patients but showed a potential benefit in a sub-population of patients exhibiting a high level of airway reversibility, suggesting a potential role on airway remodeling. Anti-IL-22 therapies have not been evaluated in asthma yet but were demonstrated efficient in severe atopic dermatitis including an effect on skin remodeling. In this review, we will address the role of Th17 cytokines in airway remodeling through data from in vitro, in vivo and translational studies, and examine the potential place of Th17-targeting therapies in the treatment of asthma with airway remodeling. Frontiers Media S.A. 2022-02-02 /pmc/articles/PMC8974749/ /pubmed/35386663 http://dx.doi.org/10.3389/falgy.2022.806391 Text en Copyright © 2022 Margelidon-Cozzolino, Tsicopoulos, Chenivesse and de Nadai. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Allergy
Margelidon-Cozzolino, Victor
Tsicopoulos, Anne
Chenivesse, Cécile
de Nadai, Patricia
Role of Th17 Cytokines in Airway Remodeling in Asthma and Therapy Perspectives
title Role of Th17 Cytokines in Airway Remodeling in Asthma and Therapy Perspectives
title_full Role of Th17 Cytokines in Airway Remodeling in Asthma and Therapy Perspectives
title_fullStr Role of Th17 Cytokines in Airway Remodeling in Asthma and Therapy Perspectives
title_full_unstemmed Role of Th17 Cytokines in Airway Remodeling in Asthma and Therapy Perspectives
title_short Role of Th17 Cytokines in Airway Remodeling in Asthma and Therapy Perspectives
title_sort role of th17 cytokines in airway remodeling in asthma and therapy perspectives
topic Allergy
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8974749/
https://www.ncbi.nlm.nih.gov/pubmed/35386663
http://dx.doi.org/10.3389/falgy.2022.806391
work_keys_str_mv AT margelidoncozzolinovictor roleofth17cytokinesinairwayremodelinginasthmaandtherapyperspectives
AT tsicopoulosanne roleofth17cytokinesinairwayremodelinginasthmaandtherapyperspectives
AT chenivessececile roleofth17cytokinesinairwayremodelinginasthmaandtherapyperspectives
AT denadaipatricia roleofth17cytokinesinairwayremodelinginasthmaandtherapyperspectives